Germline testing can identify hereditary cancer, which leads to implications for family members, cascade testing for relatives, and starting surveillance and prevention measures: Genetic testing in ...

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple ...

The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...

Accelerating the Future of Oncology Drug Development: The Role of Consortia in the Delivery of Precision Oncology Early Phase Clinical Trials ASCO Guidelines provide recommendations with comprehensive ...

Germline testing is a genetic screening that looks for inherited gene mutations found in every cell.  It can identify ...

A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...

HRR mutations are commonly of germline origin, with several real world studies suggesting a 23-44% probability of an HRR ...

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S.

A study highlights a gap in cancer prevention, showing men undergo genetic testing less often yet are more likely to carry ...

Rishi Sunak has urged men to be checked for prostate cancer as part of a new screening drive. The former prime minister has ...

Prostate cancer screening saves many more lives than earlier studies suggested, research shows. The results from the ...